Our lab has recently reported that CD99 was specifically expressed in T-ALL and that 12E7-CD28&41-BB-based anti-CD99 CAR T expanded with minor fratricide, maintaining cytotoxic function and mediating powerful antitumor effects in vitro and in vivo. The gene discussed is CD99; the disease is acute lymphoblastic leukemia.